Dr. Juan Gurria · Management of recurrent pancreatitis in pediatric patients with genetic mutations
Podcast6 min·Published May 2024Older

Management of recurrent pancreatitis in pediatric patients with genetic mutations

With Dr. Juan Gurria · hosted by Dr. Cecilia Gigena

Chapter 1 of 5

Case presentation

Case presentation: 7-year-old with recurrent pancreatitis and pancreatic duct stricture

Try
Intelligent Search· scoped to acute recurrent pancreatitis · not medical adviceSearch the whole library →
What the experts said18 expert statements · 6 host summaries
The case involves a 7-year-old with acute recurrent pancreatitis, abdominal pain, referred with ERCP showing stricture in the head of the pancreas and dilated duct distally, who has had 7 ERCPs and a stent.
ClinicalJuan Gurria
Every ERCP carries a risk of post-ERCP pancreatitis, and although the risk is low, you lose islet cells with every attack.
ClinicalJuan Gurria
PRSS1 is the most common genetic mutation in pediatric pancreatitis and is a trypsinogen activator that activates trypsin inside the pancreas.
ClinicalJuan Gurria
Other genetic mutations associated with pancreatitis include CTRC, CFTR, and CPA1.
ClinicalJuan Gurria
The Cincinnati Children's genetic panel runs 10 different genetic markers for pancreatitis.
ClinicalJuan Gurria
Genetic factors are changing the approach to pediatric chronic pancreatitis treatment.
OpinionJuan Gurria
There is currently no medication to mediate trypsin-activating mutations.
ClinicalJuan Gurria
In patients with PRSS1 mutation, a Frey procedure (partial head pancreatectomy with drainage) results in loss of islet cells and the patient will most likely continue getting pancreatitis despite ductal drainage because the parenchyma continues to be attacked by the mutation.
ClinicalJuan Gurria
A Frey procedure temporizes attacks by draining the duct but does not fix the underlying problem in genetic pancreatitis.
ClinicalJuan Gurria
There is no set number of ERCPs that defines when to stop endoscopic management.
ClinicalJuan Gurria
Surgical referral should occur sooner rather than later for evaluation, but surgery is not offered unless medical and endoscopic management have been maximized.
GuidelineJuan Gurria
When the endoscopist reports there is nothing left to balloon dilate, open, or drain, and the patient continues getting pancreatitis even with a stent, there is no reason to continue ERCPs.
ClinicalJuan Gurria
Imaging modalities used include endoscopic ultrasound, ultrasound, and CT scan as initial imaging of choice.
ClinicalJuan Gurria
MRCP is the best non-invasive study for the pancreas, particularly with different T2 sequences.
ClinicalJuan Gurria
ERCP is more therapeutic than diagnostic.
ClinicalJuan Gurria
For pancreatic fluid collections, once the wall is mature in 4 to 6 weeks, drain only if there are symptoms; if asymptomatic, do not drain.
GuidelineJuan Gurria
If the patient does not have gastric outlet obstruction or pain from a fluid collection, there is no need to drain it and it will self-resolve.
ClinicalJuan Gurria
There is no need for antibiotics for pancreatic fluid collections.
GuidelineJuan Gurria
If a patient has more than one episode of acute pancreatitis or a first severe episode, MRCP and genetic panel should be performed to rule out genetic anomalies.
Host summaryCecilia Gigena summarizes what Dr. Juan Gurria said · not cited in answers
Genetics testing is important before any resection procedure to avoid losing pancreatic cells in pathologies that will not benefit from resection and drainage but instead from islet cell transplant.
Host summaryCecilia Gigena summarizes what Dr. Juan Gurria said · not cited in answers
Endoscopic treatment should be attempted first, but if it fails, transfer to a specialized center that performs TPIAT (total pancreatectomy with islet autotransplantation).
Host summaryCecilia Gigena summarizes what Dr. Juan Gurria said · not cited in answers
Recurrent pancreatitis is a rare pathology that can lead to chronic pancreatitis and is associated with genetic mutations.
Host summaryCecilia Gigena summarizes what Dr. Juan Gurria said · not cited in answers
If genetic mutations are confirmed, partial resection of pancreatic tissue (as in a Frey procedure) should be avoided to prevent losing pancreatic cells.
Host summaryCecilia Gigena summarizes what Dr. Juan Gurria said · not cited in answers
Treatment should start with an endoscopic approach, but if it fails, TPIAT should be considered sooner rather than later.
Host summaryCecilia Gigena summarizes what Dr. Juan Gurria said · not cited in answers
GCMD Library — educational content from recorded physician discussions, not medical advice.